Chapter 5 Nonclinical evaluation of unexpected immunosuppression

Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach

Volumn 1, Issue C, 2004, Pages 163-203

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957021881     PISSN: 18739822     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1873-9822(04)80006-6     Document Type: Article

References (287)

1. Bloom J.C., Thiem P.A., and Morgan D.G. The role of conventional pathology and toxicology in evaluating the immunotoxic potential of xenobiotics. Toxicol Pathol 15 (1987) 283-292
2. Schuurman H.J., Kuiper C.F., and Vos J.G. Histopathology of the immune system as a tool to assess immunotoxicology. Toxicology 86 (1994) 187-212
3. Basketter D.A., Bremmer J.N., Buckley P., Kammuller M.E., Kawabata T., Kimber I., Loveless S.E., Magda S., Stringer D.A., and Vohr H.W. Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology. Food Chem Toxicol 33 (1995) 239-243
4. Gopinath C. Pathology of toxic effects on the immune system. Inflamm Res 2 Suppl. (1996) 74-78
5. Crevel R.W., Buckley P., Robinson J.A., and Sanders I.J. Immunotoxicological assessment of cyclosporin A by conventional pathological techniques and immune function testing in the rat. Hum Exp Toxicol 16 (1997) 79-88
6. Kuper C.F., Harleman J.H., Richter-Reihelm H.B., and Vos J.G. Histopathologic changes to detect changes indicatives of immunotoxicity. Toxicol Pathol 28 (2000) 454-466
7. Harleman J.H. Approaches to the identification and recording of findings in the lymphoreticular organs indicative for immunotoxicity in regulatory type toxicity studies. Toxicology 142 (2000) 213-219
8. The ICICIS Group Investigators, and International Collaborative Immunotoxicity Study. Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology 125 (1998) 183-201
9. Germolec D. Improving the sensitivity and predictability of current testing strategies for immunotoxicity. Toxicol Lett 149 (2004) 109-114
10. Kuper C.F., De Heer E., Van Loveren H., and Vos J.G. Immune system. In:. In: Haschek M.W., Rousseaux C.G., and Wallig M.A. (Eds). Handbook of Toxicologic Pathology. 2nd edition 2 (2002), Academic Press, San Diego 585-646
11. Kuper C.F. Issues in the histological examination of lymphoid organs. Toxicology (2004) In press
12. Schuurman H.J., Van Loveren H., Rozing G., and Vos J.G. Chemicals trophic for the thymus: risk for immunodeficiency and autoimmunity. Int J Immunopharmacol 17 (1992) 369-375
13. Irons R.D., and Stillman W.S. Flow cytofluorometric analysis of blood and bone marrow analysis. In:. In: Irons R.D. (Ed). Toxicology of the Blood and Bone Marrow (1985), Raven Press, New York 101-118
14. Martin R.A., Brott D.A., Zandee J.C., and McKeel M.J. Differential analysis of animal bone marrow by flow cytometry. Cytometry 13 (1992) 638-643
15. Criswell K.A., Bleavins M.R., Zielinski D., and Zandee J.C. Comparison of flow cytometry and manual differential in Wistar rats. Cytometry 32 (1998) 9-17
16. Weiss D.J., Blauvelt M., Sykes J., and McClenahan D. Flow cytometric evaluation of canine bone marrow differential cell counts. Vet Clin Pathol 29 (2000) 97-104
17. Burchiel S.W., Hadley W.M., Cameron C.L., et al. Analysis of heavy metal immunotoxicity by multiparameter flow cytometry: correlation of flow cytometry and immune function data in B6CF1 mice. Int J Immunopharmacol 9 (1987) 597-610
18. Dieter M.P., Jameson C.W., Tucker A.N., Luster M.I., French J.E., Hong H.L., and Boorman G.A. Evaluation of tissue disposition, myelopoietic, and immunologic responses in mice after long-term exposure to nickel sulfate in the drinking water. J Toxicol Environ Health 24 (1988) 357-372
19. De Waal E.J., Timmerman H.H., Dortant P.M., Kranjc M.A., and Van Loveren H. Investigation of a screening battery for immunotoxicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds. Regul Toxicol Pharmacol 21 (1995) 327-338
20. Graziano M.J., Galati A.J., and Walsh K.M. Immunotoxicity of the anticancer drug CI-994 in rats: effects on lymphoid tissue. Arch Toxicol 73 (1999) 168-174
21. Haley P.J. Species differences in the structure and function of the immune system. Toxicology 188 (2003) 49-71
22. Effros R.B. Immunosenescence-related diseases in the elderly. Immunol Allergy Clin North Am 13 (1993) 695-712
23. Aspinall R. Longevity and the immune response. Biogerontology 1 (2000) 273-278
24. Ginaldi L., Loreto M.F., Corsi M.P., Modesti M., and De Martinis M. Immunosenescence in infectious diseases. Microb Infect 3 (2001) 851-857
25. Dougherty T.F. Effects of hormones on lymphatic tissue. Physiol Rev 32 (1952) 379-401
26. Hall N.R., O' Grady M.P., and Menzies R.A. Thymic regulation of the hypothalamo-pituitary-gonadal axis. Int J Immunopharmacol 14 (1992) 353-359
27. Pruett S.B. Quantitative aspects of stress-induced immunomodulation. Int Immunopharmacol 1 (2001) 507-520
28. Moynihan J.A. Mechanisms of stress-induced modulation of immunity. Brain Behav Immun 17 Suppl. (2003) 11-16
29. Mittal A., Woodward B., and Chandra R.K. Involution of thymic epithelium and low thymulin bioactivity in weanling mice subjected to severe food intake restriction or severe protein deficiency. Exp Mol Pathol 48 (1988) 226-235
30. Barone K.S., O'Brien P.C.M., and Stevenson J.R. Characterization and mechanism of thymic atrophy in protein-malnourished mice: role of corticosterone. Cell Immunol 148 (1993) 226-233
31. Bohus B., Koolhaas J.M., de Ruiter A., and Heijnen C.J. Stress and differential alterations in immune system functions: conclusions from social stress studies in animals. Neth J Med 39 (1991) 306-311
32. Kendall M.D., and Ritter M.A. The Thymus in Immunotoxicology. Harwood, Chur. (1991)
33. De Waal E.J., Rademakers L.H., Schuurman H.J., Van Loveren H., and Vos J.G. Ultrastructure of the cortical epithelium of the rat thymus after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Arch Toxicol 67 (1993) 558-564
34. Pieters R.H., Bol M., Seinen W., and Penninks A.H. Cellular and molecular aspects of organotin-induced thymus atrophy. Hum Exp Toxicol 13 (1994) 876-879
35. Miller K., Scott M.P., and Foster J.R. Thymic involution in rats give diets containing dioctyltin dichloride. Clin Immunol Immunopathol 30 (1984) 62-70
36. De Waal E.J., Timmerman H.H., Dortant P.M., Kranjc M.A., and Van Loveren H. Investigation of a screening battery for immunotoxicity of pharmaceuticals within a 28-day oral toxicity study using azathioprine and cyclosporin A as model compounds. Regul Toxicol Pharmacol 21 (1995) 327-338
37. Descotes G., Pinard D., Gallas J.F., Penacchio E., Blot C., and Moreau C. Extension of the 4-week safety study for detecting immune system impairment appears not necessary: example of cyclosporin A in rats. Toxicology 112 (1996) 245-256
38. Institoris L., Siroki O., Desi I., Lesznyak J., Serenyi P., Szekeres E., and Petri I. Extension of the protocol of OECD guideline 407. (28-day repeated dose oral toxicity test in the rat) to detect potential immunotoxicity of chemicals. Hum Exp Toxicol 17 (1998) 206-211
39. Richter-Reichhelm H.B., and Schulte A.E. Results of a cyclosporin A ringstudy. Toxicology 129 (1998) 91-94
40. Pugh-Humphrey R.G.P., Ross C.S.K., and Thomson A.W. The influence of FK-506 on the thymus: an immunophenotypic and structural analysis. Immunology 70 (1990) 398-404
41. Takai K., Tokuda N., and Sawada T. Effects of FK506 on rat thymic epithelial cells: immunohistochemical study. Thymus 19 (1992) 207-217
42. Wijnen R.M., de Heer C., de Jong W., Buurman W., and van Loveren H. Thymus atrophy in the nonhuman primate by FK506: an immunohistochemical study. Transplant Proc 29 (1997) 1246-1249
43. Whiting P.H., Woo J., Adam B.J., Hasan N.U., Davidson R.J., and Thomson A.W. Toxicity of rapamycin-a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. Transplantation 52 (1991) 203-208
44. Houben G.F., and Penninks A.H. Immunotoxicity of the colour additive caramel colour III; a review on complicated issues in the safety evaluation of a food additive. Toxicology 91 (1994) 289-302
45. Okasha S.A., Ryu S., Do Y., McKallip R.J., Nagarkatti M., and Nagarkatti P.S. Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163 (2001) 49-62
46. Gould K.A., Shull J.D., and Gorski J. DES action in the thymus: inhibition of cell proliferation and genetic variation. Mol Cell Endocrinol 170 (2000) 31-39
47. Yang Q., Xie Y., and Depierre J.W. Effects of peroxisome proliferators on the thymus and spleen of mice. Clin Exp Immunol 122 (2000) 219-226
48. Cuff C.F., Zhao W., Nukui T., Schafer R., and Barnett J.B. 3,4-Dichloropropionanilide-induced atrophy of the thymus: mechanisms of toxicity and recovery. Fundam Appl Toxicol 33 (1996) 83-90
49. Enan E., Pinkerton K.E., Peake J., and Matsumura F. Deltamethrin-induced thymus atrophy in male Balb/c mice. Biochem Pharmacol 51 (1996) 447-454
50. Upreti R.K., Singh K.P., Saxena A.K., and Shanker R. Effect of 2,5-hexanedione on lymphoid organs of rats: a preliminary report. Environ Res 39 (1986) 188-198
51. Luster M.I., Portier C., Pait D.G., White K.L., Gennings C., Munson A.E., and Rosenthal G.J. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18 (1992) 200-210
52. Kawabata T.T., Burleson G.R., Ernst P.B., and Ullrich S.B. Immunotoxicology of regional lymphoid tissue: the respiratory and gastrointestinal tracts and skin. Fundam Appl Toxicol 26 (1995) 8-19
53. Bandaletova T.Y. Morphogenesis of epithelial lesions in the lymphoid patches of Fischer 344 rats during cyclosporine-A-induced prolonged immunosuppression. Tumori 78 (1992) 366-369
54. Mazigh D., Alonso J.M., and Mollaret H.H. Cellular depletion in Peyer's patches after cyclophosphamide treatment in mice. Ann Microbiol 130 B (1979) 333-339
55. Nagata T., Suzuki H., Ishigami N., Shinozuka J., Uetsuka K., Nakayama H., and Doi K. Development of apoptosis and changes in lymphocyte subsets in thymus, mesenteric lymph nodes and Peyer's patches of mice orally inoculated with T-2 toxin. Exp Toxicol Pathol 53 (2001) 309-315
56. Davis D.P., Gomez M.P., Barton S.L., Montano R.M., and Burchiel S.W. Suppression of local gut-associated and splenic mitogen responsiveness of lymphoid cells following oral exposure of B6C3F1 mice to 7,12-dimethylbenz[a]anthracene. Fundam Appl Toxicol 17 (1991) 429-431
57. Hall R.L. Principles of clinical pathology for toxicology studies. In:. In: Hayes A.W. (Ed). Principles and Methods of Toxicology. 4th edition (2001), Taylor & Francis, Philadelphia 1001-1038
58. Smith G.S., Hall R.L., and Walker R.M. Applied clinical pathology in preclinical toxicology testing. In:. In: Hascherk W., Rousseaux C.O., and Wallig M.A. (Eds). Handbook of Toxicologic Pathology. 2nd edition 1 (2002), Academic Press, San Diego 123-156
59. Rich I.N. In vitro hematotoxicity testing in drug development: a review of past, present and future applications. Curr Opin Drug Discov Dev 6 (2003) 100-109
60. Boorman G.A., Luster M.I., Dean J.H., and Campbell M.L. Assessment of myelotoxicity induced by environmental chemicals. Environ Health Perspect 43 (1982) 129-135
61. Wierda D., and Irons R.D. Bone marrow and immunotoxicity. In:. In: Smialowicz R.J., and Holsapple M.P. (Eds). Experimental Immunotoxicity (1996), CRC Press, Boca Raton 101-117
62. Marti G.E., Stetler-Stevenson M., Bleesing J.J., and Fleisher T.A. Introduction to flow cytometry. Semin Hematol 38 (2001) 93-99
63. Peakman M., Tredger J.M., Davies E.T., Davenport M., Dunne J.B., Williams R., and Vergani D. Analysis of peripheral blood mononuclear cells in rodents by three-colour flow cytometry using a small-volume lysed whole blood technique. J Immunol Methods 158 (1993) 87-94
64. Weaver J.L., Broud B.D., McKinnon K., and Germolec D. Serial phenotypic analysis of mouse peripheral blood lymphocytes. Toxicol Mech Methods 12 (2002) 95-118
65. Ladics G.S., and Loveless S.E. Cell surface marker analysis of splenic lymphocyte populations of the CD rat for use in immunotoxicological studies. Toxicol Methods 4 (1994) 77-91
66. Morris D.L., and Komocsar W.J. Immunophenotying analysis of peripheral blood, splenic and thymic lymphocytesin male and female rats. J Pharmacol Toxicol Methods 37 (1997) 37-46
67. Faldyna M., Leva L., Knotigova P., and Toman M. Lymphocyte subsets in peripheral blood of dogs-a flow cytometric study. Vet Immunol Immunopathol 82 (2001) 23-37
68. Boeker M., Pabst R., and Rothkotter H.J. Quantification of B, T and null lymphocyte subpopulations in the blood and lymphoid organs of the pig. Immunobiology 201 (1999) 74-87
69. Stabel T.J., Bolin S.R., Pesch B.A., and Rahner T.E. A simple and rapid flow cytometric method for detection of porcine cell surface markers. J Immunol Methods 245 (2000) 147-152
70. Neubert R., Foerster M., Nogueira A.C., and Helge H. Cross-reactivity of antihuman monoclonal antibodies with cell surface receptors in the common marmoset. Life Sci 58 (1996) 317-324
71. Brok H.P., Hornby R.J., Griffiths G.D., Scott L.A., and Hart B.A. An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. Cytometry 45 (2001) 294-303
72. Verdier F., Aujoulat M., Condevaux F., and Descotes J. Determination of lymphocyte subsets and cytokine levels in cynomolgus monkeys. Toxicology 105 (1995) 81-90
73. Sopper S., Stahl-Hennig C., Demuth M., Johnston I.C., Dorries R., and ter Meulen V. Lymphocyte subsets and expression of differentiation markers in blood and lymphoid organs of rhesus monkeys. Cytometry 29 (1997) 351-362
74. Nam K.H., Akari H., Terao K., Itagaki S., and Yoshikawa Y. Age-related changes in major lymphocyte subsets in cynomolgus monkeys. Exp Anim 47 (1998) 159-166
75. Dykhuizen M., Ceman J., Mitchen J., Zayas M., MacDougall A., Helgeland J., Rakasz E., and Pauza C.D. Importance of the CD3 marker for evaluating changes in rhesus macaque CD4/CD8 T-cell ratios. Cytometry 40 (2000) 69-75
76. Lafont B.A., Gloeckler L., D' Hautcourt J.L., Gut J.P., and Aubertin A.M. One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry. Cytometry 41 (2000) 193-202
77. Nygaard U.C., and Lovik M. Blood and spleen lymphocytes as targets for immunotoxic effects in the rat-a comparison. Toxicology 174 (2002) 153-161
78. Luster M.I., Portier C., Pait D.G., Rosenthal G.J., Germolec D.R., Corsini E., Blaylock B.L., Pollock P., Kouchi Y., and Craig W. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam Appl Toxicol 21 (1993) 71-82
79. Immunotoxicology Technical Committee. Application of flow cytometry to immunotoxicity testing: summary of a workshop. Toxicology 163 (2001) 39-48
80. Vandebriel R.J., Spiekstra S.W., Hudspith B.N., Meredith C., and Van Loveren H. In vitro exposure effects of cyclosporin A and bis(tri-n-butyltin)oxide on lymphocyte proliferation, cytokine (receptor) mRNA expression, and cell surface marker expression in rat thymocytes and splenocytes. Toxicology 135 (1999) 49-66
81. Burchiel S.W., Lauer F.T., Gurule D., Mounho B.J., and Salas V.M. Uses and future applications of flow cytometry in immunotoxicity testing. Methods 19 (1999) 28-35
82. Caruso A., Licenziati S., Corulli M., Canaris A.D., De Francesco M.A., Fiorentini S., Peroni L., Fallacara F., Dima F., Balsari A., and Turano A. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 27 (1997) 71-76
83. Steensma D.P., Timm M., and Witzig T.E. Flow cytometric methods for detection and quantification of apoptosis. Methods Mol Med 85 (2003) 323-332
84. Schreiber M., Kantimm D., Kirchhoff D., Heimann G., and Bhargava A.S. Concentrations in serum of IgG, IgM and IgA and their age-dependence in beagle dogs as determined by a newly developed enzyme-linked-immuno-sorbent-assay (ELISA). Eur J Clin Chem Clin Biochem 30 (1992) 775-778
85. Salauze D., Serre V., and Perrin C. Quantification of total IgM and IgG levels in rat sera by a sandwich ELISA technique. Comp Haematol 4 (1994) 30-32
86. Bianchi A.T., Moonen-Leusen H.W., van der Heijden P.J., and Bokhout B.A. The use of a double antibody sandwich ELISA and monoclonal antibodies for the assessment of porcine IgM, IgG and IgA concentrations. Vet Immunol Immunopathol 44 (1995) 309-317
87. Ginel P.J., Margarito J.M., Lucena R., and Molleda J.M. Concentrations of plasma immunoglobulins in the dog as determined by laser nephelometry. Comparison with radial immunodiffusion and enzyme-linked immunosorbent assay. Eur J Clin Chem Clin Biochem 35 (1997) 223-228
88. Ladics G.S., Smith C., Heaps K., Elliott G.S., Slone T.W., and Loveless S.E. Possible incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats on standard toxicology study. Toxicology 96 (1995) 225-238
89. Ladics G.S., Smith C., Elliott G.S., Slone T.W., and Loveless S.E. Further evaluation of the incorporation of an immunotoxicological functional assay for assessing humoral immunity for hazard identification purposes in rats in a standard toxicology study. Toxicology 126 (1998) 137-152
90. Condevaux F., Guichard J., Eltschinger N., Crétinon C., Horand F., and Descotes J. Comparison of the effects of cyclophosphamide and dexamethasone on PFC assay, anti-KLH and anti-tetanus toxoid ELISA responses in rats. 43rd Annual Meeting of the Society of Toxicology (2004) Baltimore, 21-24 March
91. Wilson S.D., Munson A.E., and Meade B.J. Assessment of the functional integrity of the humoral immune response: the plaque-forming cell assay and the enzyme-linked immunosorbent assay. Methods 19 (1999) 3-7
92. Jokinen I., Poikonen K., and Arvilommi H. Synthesis of human immunoglobulins in vitro: comparison of two assays of secreted immunoglobulin. J Immunoassay 6 (1985) 1-9
93. Petersen J., Feldt-Rasmussen U., Larsen F., and Siersbaek-Nielsen K. Autoreactive lymphocytes in thyroid disorders. II. Comparison of anti-thyroglobulin antibody production by plaque-forming cell, radio-immuno-logical and enzyme-linked immunosorbent assays. Acta Pathol Microbiol Immunol Scand [C] 94 (1986) 113-117
94. Temple L., Kawabata T.T., Munson A.E., and White K.L. Comparison of ELISA and plaque-forming cell assays for measuring the humoral response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam Appl Toxicol 21 (1993) 412-419
95. Johnson C.W., Williams W.C., Copeland C.B., DeVito M.J., and Smialowicz R.J. Sensitivity of the SRBC PFC assay versus ELISA for detection of immunosuppression by TODD and TCDD-like congeners. Toxicology 156 (2000) 1-11
96. Condevaux F., Horand F., Ruat C., and Descotes J. Relative sensitivities of the plaque forming cell (PFC) assay and anti-KLH antibody ELISA in the same rats treated with cyclophosphamide. Toxicol Lett 123 Suppl. 1 (2001) 58 (abstract)
97. Frisch A.W., and Davies G.H. The inhibition of hemagglutinin formation in mice by purine and pyrimidine analogues. J Immunol 88 (1962) 269-273
98. Dietrich F.M. Inhibition of antibody formation to sheep erythrocytes by various tumour-inhibiting chemicals. Int Arch Allergy 29 (1966) 313-328
99. Nyerges G., Virag E., and Lutter J. The potency testing of diphtheria and tetanus toxoids as determined by the induction of antibody in mice. J Biol Stand 11 (1983) 99-103
100. Ershler W.B., Hacker M.P., Burroughs B.J., Moore A.L., and Myers C.F. Cimetidine and the immune response. I. In vivo augmentation of nonspecific and specific immune response. Clin Immunol Immunopathol 26 (1983) 10-17
101. Akay M.T., Ozmen G., and Elcuman E.A. Effects of combinations of endosulfan, dimethoate and carbaryl on immune and hematological parameters of rats. Vet Hum Toxicol 41 (1999) 296-299
102. Banerjee B.D., Pasha S.T., Hussain Q.Z., Koner B.C., and Ray A. A comparative evaluation of immunotoxicity of malathion after subchronic exposure in experimental animals. Indian J Exp Biol 36 (1998) 273-282
103. Rosenberg H., McDonald T.L., and Modrak J.B. Influence of chronic lead ingestion on IgG subclass expression of the immune response to bovine serum albumin. Drug Chem Toxicol 8 (1985) 57-67
104. Dostal M., Benesova O., Tejkalova H., and Soukupova D. Immune response of adult rats is altered by administration of diazepam in the first postnatal week. Reprod Toxicol 9 (1995) 115-121
105. Brown P.A., Thomson A.W., Whiting P.H., Davidson R.J., and Simpson J.G. Immunosuppressive activity and toxicity of cyclosporin A in rats pretreated with high dose cyclophosphamide. Agents Actions 17 (1985) 67-72
106. Banerjee B.D., Ray A., and Pasha S.T. A comparative evaluation of immunotoxicity of DDT and its metabolites in rats. Indian J Exp Biol 34 (1996) 517-522
107. Dearman R.J., Caddick H., Stone S., Basketter D.A., and Kimber I. Characterization of antibody responses induced in rodents by exposure to food proteins: influence of route of exposure. Toxicology 167 (2001) 217-231
108. Mond J.J., Vos Q., Lees A., and Snapper C.M. T cell independent antigens. Curr Opin Immunol 7 (1995) 349-354
109. Dean J.H., Luster M.I., Boorman G.A., Lauer L.D., Leubke R.W., and Lawson L. Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice. Clin Exp Immunol 52 (1983) 199-206
110. Jeme N.K., Henry C., Nordin A.A., Fuji H., Koros A.M., and Lefkovits I. Plaque forming cells: methodology and theory. Transplant Rev 18 (1974) 130-191
111. Borel J.F. Comparison of the immune response to sheep erythrocytes, tetanus toxoid and endotoxin in different strains of mice. Agents Actions 4 (1974) 277-285
112. Jeme N.K., and Nordin A.A. Plaque formation in agar by single antibody-producing cells. Science 140 (1963) 405
113. Cunnigham A.J., and Szenberg A. Further improvements in plaque technique for detecting single antibody-forming cells. Immunology 14 (1968) 599-600
114. Emstrom U., and Soder O. Influence of adrenaline on the dissemination of antibodyproducing cells from the spleen. Clin Exp Immunol 21 (1975) 131-140
115. Lis T., and Mierzejewski J. Inhibition of immune response by diisopropyl phosphorofluoridate. Arch Toxicol 4 Suppl. (1980) 151-155
116. Burn L.A., Duwe R.L., and Jovanovic M.L. Development and validation of the antibodyforming cell response as an immunotoxicological endpoint in the guinea-pig. Toxicol Methods 6 (1996) 193-212
117. Rama Rao G.V., Cain C.A., and Tompkins W.A. Effects of microwave exposure on the hamster immune system. IV. Spleen cell IgM hemolytic plaque formation. Bioelectromagnetics 6 (1985) 41-52
118. Gieldanowski J., Blaszczyk B., Raberger G., and Dus D. Investigations on pharmacological and immunological properties of imuthiol. Arch Immunol Ther 38 (1990) 249-258
119. Gengozian N., Salter B.L., Basford N.L., and Kateley J.R. Characterization of the antibody response of the marmoset to sheep red blood cells. Clin Exp Immunol 23 (1976) 525-535
120. Nikolova S., Najdenski H., and Wesselinova D. Immunological and electron microscopic studies in pigs infected with Yersinia enterocolitica 0:3. Zentralbl Bakteriol 286 (1997) 503-510
121. Heyman B., Holmquist G., Borwell P., and Heyman U. An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies. J Immunol Methods 68 (1984) 193-204
122. Mori H., Sakamoto O., Xu Q.A., Daikoku M., and Koda A. Solid phase enzyme-linked immunosorbent assay (ELISA) for anti-sheep erythrocyte antibody in mouse serum. Int J Immunopharmacol 11 (1989) 597-606
123. Van Loveren H., Verlaan A.P., and Vos J.G. An enzyme-linked immunosorbent assay of antisheep red blood cell antibodies of the classes M, G, and A in the rat. Int J Immunopharmacol 13 (1991) 689-695
124. Smith H.W., Winstead C.J., Stank K.K., Halstead B.W., and Wierda D. A predictive F344 rat immunotoxicology model: cellular parameters combined with humoral response to NPCgammaG and KLH. Toxicology 194 (2003) 129-145
125. Gore E.R., Gower J., Kurali E., Sui J.L., Bynum J., Ennulat D., and Herzyk D.J. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Toxicology 194 (2004) 23-35
126. Ulrich P., Paul G., Perentes E., Mahl A., and Roman D. Validation of immune function testing during a 4-week oral toxicity study with FK506. Toxicol Lett 149 (2004) 123-131
127. Vos J.G., Krajnc E., and Beekhof P. Use of the enzyme-linked immunosorbent assay (ELISA) in immunotoxicity testing. Environ Health Perspect 43 (1982) 115-121
128. Czerkinsky C.C., Nilsson L.A., Nygren H., Outcherlony O., and Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 65 (1983) 109-121
129. Franci C., Ingles J., Castro R., and Vidal J. Further studies on the ELISA-spot technique. Its application to particulate antigens and a potential improvement in sensitivity. J Immunol Methods 88 (1986) 225-232
130. Kawabata T.T. Enumeration of antigen-specific antibody-forming cells by the enzymelinked immunospot (ELISPOT) assay. In:. In: Burleson G., Dean J.H., and Munson A.E. (Eds). Methods in Immunotoxicology 1 (1995), Wiley-Liss, New York 125-135
131. Schielen P., van Rodijnen W., Tekstra J., Albers R., and Seinen W. Quantification of natural antibody producing B cells in rats by an improved ELISPOT technique using the polyvinylidene difluoride membrane as the solid support. J Immunol Methods 188 (1995) 33-41
132. Schielen P., Van Rodijnen W., Pieters R.H., and Seinen W. Hexachlorobenzene treatment increases the number of splenic B-1-like cells and serum autoantibody levels in the rat. Immunology 86 (1995) 568-574
133. Hurtrel B., Hurtrel M., and Lagrange P.H. Time course and histological differences between sheep red blood cells and tuberculin DTH reactions in mice. Ann Immunol 135 C (1984) 219-230
134. Luster M.I., Dean J.H., and Boorman G.A. Cell-mediated immunity and its application to toxicology. Environ Health Perspect 43 (1982) 31-36
135. Van der Kwast T.H., and Benner R. Distribution of cells mediating delayed type hypersensitivity responses of mice to sheep red blood cells. Ann Immunol 128 C (1977) 833-840
136. Kettman J., Skarvall H., and Mathews M. Delayed-type hypersensitivity in the mouse: effect of vinblastine on sensitization by sheep red blood cells. Immunopharmacology 2 (1979) 73-82
137. Webster L.M., and Thomson A.W. Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes. Immunology 60 (1987) 409-414
138. Fujimaki H., Shimizu F., Kawamura R., and Kubota K. Inhibition of delayed hypersensitivity reaction in mice by cadmium. Toxicol Lett 19 (1983) 241-245
139. Webster L.M., and Thomson A.W. Improved quantitation of delayed-type hypersensitivity responses to sheep erythrocytes in the mouse footpad by estimation of 1251-fibrin deposition. J Immunol Methods 106 (1988) 277-781
140. Robinson J.H., and Naysmith J.D. A comparison of four methods for measuring cutaneous delayed-type hypersensitivity reactions to protein antigens in the mouse. Scand J Immunol 5 (1976) 299-304
141. Holsapple M.P., Page D.G., Bick P.H., and Shopp G.M. Characterization of the delayed hypersensitivity response to a protein antigen in the mouse-1. Kinetics of reactivity and sensitivity to classical immunosuppressants. Int J Immunopharmacol 6 (1984) 399-405
142. Johnson K.W., Holsapple M.P., and Munson A.E. An immunotoxicological evaluation of gamma-chlordane. Fundam Appl Toxicol 6 (1986) 317-326
143. Drach G., and Chen-Marotel J. Delayed type hypersensitivity to bovine serum albumin and to lipid-conjugated bovine serum albumin in mice. Int Arch Allergy Appl Immunol 59 (1979) 28-33
144. Henningsen G.M., Koller L.D., Exon J.H., Talcott P.A., and Osborne C.A. A sensitive delayedtype hypersensitivity model in the rat for assessing in vivo cell-mediated immunity. J Immunol Methods 70 (1984) 153-165
145. Ross P.S., De Swart R.L., Reijnders P.J., Van Loveren H., Vos J.G., and Osterhaus A.D. Contaminant-related suppression of delayed-type hypersensitivity and antibody responses in harbor seals fed herring from the Baltic Sea. Environ Health Perspect 103 (1995) 162-167
146. Banerjee B.D., Ray A., and Pasha S.T. A comparative evaluation of immunotoxicity of DDT and its metabolites in rats. Indian J Exp Biol 34 (1996) 517-522
147. Bleavins M.R., and de la Iglesia F.A. Cynomolgus monkeys (Macaca fascicularis) in preclinical immune function safety testing: development of a delayed-type hypersensitivity procedure. Toxicology 95 (1995) 103-112
148. Mendenhall C.L., Grossman C.J., Roselle G.A., Ghosn S.J., Coyt T.Y., Thompson S., and Dehne N.E. Phytohemagglutinin skin test responses to evaluate in vivo cellular immune function in rats. Proc Soc Exp Biol Med 190 (1989) 117-120
149. Tamura S., Kurata T., Sugimoto M., and Egashira Y. Cellular and humoral immune responses in mice. I. Development of delayed-type footpad swelling against sheep erythrocytes and its suppression by intraperitoneal administration of the antigen. Jpn J Med Sci Biol 26 (1973) 161-168
150. Titus R.G., and Chiller J.M. A simple and effective method to assess murine delayed type hypersensitivity to proteins. J Immunol Methods 45 (1981) 65-78
151. Garzelli C., Colizzi V., Campa M., and Falcone G. Mouse footpad infection by Pseudomonas aeruginosa: evidence for delayed hypersensitivity to specific bacterial antigen. Med Microbiol Immunol 168 (1980) 111-118
152. Ohuchi K., Yoshino S., and Kurihara A. Delayed-type hypersensitivity as revealed on the footpads of mice to azobenzenearsonate-acetyl bovine serum albumin. Int Arch Allergy Appl Immunol 66 (1981) 391-403
153. Descotes J., Tedone R., and Evreux J.C. Effects of cimetidine and ranitidine on delayed-type hypersensitivity. Immunopharmacology 6 (1983) 31-35
154. Descotes J., Tedone R., and Evreux J.C. Different effects of psychotropic drugs on delayed hypersensitivity responses in mice. J Neuroimmunol 9 (1985) 81-85
155. Pearson L.D., Osebold J.W., and Wagner P.C. A device for measuring the volume of footpad swelling from delayed hypersensitivity reactions in mice. Lab Anim Sci 21 (1971) 591-593
156. Van Dijk H., Versteeg H., and Hennink H.J. A semi-electronic device for measuring delayed hypersensitivity in the mouse by footpad swelling. J Immunol Methods 12 (1976) 261-265
157. Vadas M.A., Miller J.F., Gamble J., and Whitelaw A. A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol 49 (1975) 670-692
158. Franco M.F., and Morley J. Use of 1251-labelled albumin for the detection and measurement of delayed-hypersensitivity reactions in the mouse. J Immunol Methods 11 (1976) 7-14
159. Webster L.M., and Thomson A.W. Improved quantitation of delayed-type hypersensitivity responses to sheep erythrocytes in the mouse footpad by estimation of 1251-fibrin deposition. J Immunol Methods 106 (1988) 277-281
160. Kitamura K. A footpad weight assay method to evaluate delayed-type hypersensitivity in the mouse. J Immunol Methods 39 (1980) 277-383
161. Ponton J., Regulez P., and Cisterna R. Comparison of three tests for measuring footpad swelling in the mouse. J Immunol Methods 63 (1983) 139-143
162. Robinson J.H., and Naysmith J.D. A comparison of four methods for measuring cutaneous delayed-type hypersensitivity reactions to protein antigens in the mouse. Scand J Immunol 5 (1976) 299-304
163. Thilsted J.P., and Shifrine M. Delayed cutaneous hypersensitivity in the dog: reaction to tuberculin purified protein derivative and coccidioidin. Am J Vet Res 39 (1978) 1702-1705
164. Thilsted J.P., Shifrine M., and Wiger N. Correlation of in vitro and in vivo tests for cellmediated immunity in the dog. Am J Vet Res 40 (1979) 1313-1315
165. Reed M.J., Borkow I., and Staple P.H. Immune response to keyhole limpet hemocyanin and oral Actinomyces viscosus antigens in Macaca arctoides. J Periodontol 52 (1981) 111-118
166. Back O., and Larsen A. Contact sensitivity in mice evaluated by means of ear swelling and a radiometric test. J Investig Dermatol 78 (1982) 309-312
167. Descotes J., Tedone R., and Evreux J.C. Immunotoxicity screening of drugs and chemicals: value of contact hypersensitivity to picryl chloride in the mouse. Methods Find Exp Clin Pharmacol 7 (1985) 303-305
168. Kenny M.T. Effect of rifampin and its cyclopentyl analogue, MDL 473, on the expression of delayed type hypersensitivity to oxazolone. Int J Immunopharmacol 9 (1987) 257-260
169. Robinson M.K., and Sozeri T.J. Immunosuppressive effects of clonidine on the induction of contact sensitization in the balb/c mouse. J Investig Dermatol 95 (1990) 587-591
170. Sy M.S., Miller S.D., and Claman H.N. Immune suppression with supraoptimal doses of antigen in contact sensitivity. 1. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol 119 (1977) 240-244
171. Horiuchi H., Ota M., Kitahara S., Ohta T., Kiyoki M., and Komoriya K. Allopurinol increases ear swelling and mortality in a dinitrofluorobenzene-induced contact hypersensitivity mouse model. Biol Pharm Bull 22 (1999) 810-815
172. Maguire H.C., and Maibach H.I. Effect of cyclophosphamide, 6-mercaptopurine, actinomycin D and vincaleukoblastine on the acquisition of delayed hypersensitivity (DNCB contact dermatitis) in the guinea-pig. J Investig Dermatol 37 (1961) 427-431
173. Descotes J., and Evreux J.C. Effect of chlorpromazine on contact hypersensitivity to DNCB in the guinea-pig. J Neuroimmunol 2 (1982) 21-25
174. Austad J., and Mork N.J. Effects of short-wave ultraviolet light (UVB) on delayed hypersensitivity in the guinea pig. Acta Derm Venereol 62 (1982) 133-136
175. Lagodzinski Z., Gorski A., and Wasik M. Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice. Immunology 71 (1990) 148-150
176. Chuong P.H., Galons H., Voisin J., Zhu J., Righenzi S., Warnet J.M., Claude J.R., and Huynh-Thien D. In vitro and in vivo immunosuppressive potential of thalidomide and its derivative, N-hydroxythalidomide, alone and in combination with cyclosporin A. Int J Immunopharmacol 19 (1997) 289-296
177. Nowell P.C. Differentiation of human leukemic leukocytes in tissue culture. Exp Cell Res 19 (1960) 267-277
178. Nowell P.C. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res 20 (1960) 462-466
179. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
180. Gerlier D., and Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 94 (1986) 57-63
181. Loveland B.E., Johns T.G., Mackay I.R., Vaillant F., Wang Z.X., and Hertzog P.J. Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem Int 27 (1992) 501-510
182. Roehm N.W., Rodgers G.H., Hatfield S.M., and Glasebrook A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142 (1991) 257-265
183. Van Furth R., and Van Zwet T.L. Immunocytochemical detection of 5-bromo-2-deoxyuridine incorporation in individual cells. J Immunol Methods 108 (1988) 45-51
184. Sasaki K., Murakami T., Ogino T., Takahashi M., and Kawasaki S. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine. Cytometry 7 (1986) 391-395
185. Wemme H., Pfeifer S., Heck R., and Muller-Quernheim J. Measurement of lymphocyte proliferation: critical analysis of radioactive and photometric methods. Immunobiology 185 (1992) 78-89
186. Messele T., Roos M.T., Hamann D., Koot M., Fontanet A.L., Miedema F., Schellekens P.T., and Rinke de Wit T.F. Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the 3H-thymidine incorporation assay. Clin Diagn Lab Immunol 7 (2000) 687-692
187. Tucker A.N., Bucher J.R., Germolec D.R., Silver M.T., Vore S.J., and Luster M.I. Immunological studies on mice exposed subacutely to methyl isocyanate. Environ Health Perspect 72 (1987) 139-141
188. Smialowicz R.J., Riddle M.M., Rogers R.R., Luebke R.W., and Copeland C.B. Immunotoxicity of tributyltin oxide in rats exposed as adults or pre-weanlings. Toxicology 57 (1989) 97-111
189. Hajoui O., Flipo D., Mansour S., Fournier M., and Krzystyniak K. Immunotoxicity of subchronic versus chronic exposure to aldicarb in mice. Int J Immunopharmacol 14 (1992) 1203-1211
190. Kunimatsu T., Kamita Y., Isobe N., and Kawasaki H. Immunotoxicological insignificance of fenitrothion in mice and rats. Fundam Appl Toxicol 33 (1996) 246-253
191. Karrow N.A., McCay J.A., Brown R., Musgrove D., Munson A.E., and White K.L. Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice. Drug Chem Toxicol 23 (2000) 621-644
192. House R.D., and Dean J.H. Studies on structural requirements for suppression of cytotoxic T lymphocyte induction by polycyclic compounds. In Vitr Toxicol 1 (1987) 149-162
193. Hanson C.D., and Smialowicz R.J. Evaluation of the effect of low-level 2, 3, 7, 8tetrachlorodibenzo p-dioxin exposure on cell mediated immunity. Toxicology 88 (1994) 213-224
194. Kerkvliet N.I., Baecher-Steppan L., and Shepherd D.M. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2, 3, 7, 8-tetrachlorodibenzop-dioxin. J Immunol 157 (1996) 2310-2319
195. Li Q., Minami M., and Inagaki H. Acute and subchronic immunotoxicity of pchloronitrobenzene in mice. I. Effect on natural killer, cytotoxic T-lymphocyte activities and mitogen-stimulated lymphocyte proliferation. Toxicology 127 (1998) 223-332
196. Lecoeur H., Fevrier M., Garcia S., Riviere Y., and Gougeon M.L. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 253 (2001) 177-187
197. Hoppner M., Luhm J., Schlenke P., Koritke P., and Frohn C. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J Immunol Methods 267 (2002) 157-163
198. Bienvenu J.A., Monneret G., Gutowski M.C., and Fabien N. Cytokine assays in human sera and tissues. Toxicology 129 (1998) 55-61
199. House R.V. Theory and practice of cytokine assessment in immunotoxicology. Methods 19 (1999) 17-27
200. Delarche C., and Chollet-Martin S. Plasma cytokines: what we are measuring. Curr Opin Clin Nutr Metab Care 2 (1999) 475-479
201. Langezaal I., Coecke S., and Hartung T. Whole blood cytokine response as a measure of immunotoxicity. Toxicol In Vitro 15 (2001) 313-318
202. Moszczynski P., Rutowski J., Slowinski S., and Jakus-Stoga D. Usefulness of immunologic and protein determinations for assessment of exposure to mercury. Przegl Lek 53 (1996) 143-146
203. Rutowski J., Moszczynski P., Dobrowolski J.W., Bern S., and Krochmal D. The effects of occupational exposure to nitrogen dioxide (N02) on the immunological parameters in workers. Med Pr 49 (1998) 341-351
204. Megiran R., and Leonardi D. Effect of methotrexate on the blood clearances of carbon after India ink. J Reticuloendoth Soc 3 (1966) 295-304
205. Al Tuwaijri A., and Saad A.H. Reevaluation of some of the kinetics of carbon colloid clearance by the mononuclear phagocyte system in vivo. Br J Exp Pathol 67 (1986) 251-258
206. Vos J.G., De Klerk A., Krajnc E.I., Van Loveren H., and Rozing J. Immunotoxicity of bis(tri-nbutyltin)oxide in the rat: effects on thymus-dependent immunity and on nonspecific resistance following long-term exposure in young versus aged rats. Toxicol Appl Pharmacol 105 (1990) 144-155
207. Verdier F., Virat M., Schweinfurth H., and Descotes J. Immunotoxicity of bis(tri-n-butyltin) oxide in the rat. J Toxicol Environ Health 32 (1991) 307-317
208. De Waal E.J., Van Der Laan J.W., and Van Loveren H. Effects of prolonged exposure to morphine and methadone on in vivo parameters of immune function in rats. Toxicology 129 (1998) 201-210
209. Yang H.M., Antonini J.M., Barger M.W., Butterworth L., Roberts B.R., Ma J.K., Castranova V., and Ma J.Y. Diesel exhaust particles suppress macrophage function and slow the pulmonary clearance of Listeria monocytogenes in rats. Environ Health Perspect 109 (2001) 515-521
210. Antonini J.M., Roberts J.R., Clarke R.W., Yang H.M., Barger M.W., Ma J.Y., and Weissman D.N. Effect of age on respiratory defense mechanisms: pulmonary bacterial clearance in Fischer 344 rats after intratracheal instillation of Listeria monocytogenes. Chest 120 (2001) 240-249
211. Simpson D.W., Roth R., and Loose L.D. A rapid, inexpensive and easily quantified assay for phagocytosis and microbicidal activity of macrophages and neutrophils. J Immunol Methods 29 (1979) 221-226
212. Desnottes J.F., Jacotot F., Bruel J., Bassoullet M.T., and Niel G. Effects of pefloxacin on phagocytosis function of rat macrophages and polymorphonuclear leucocytes. J Antimicrob Chemother 17 (1986) 53-57
213. Vonk A.G., Wieland C.W., Netea M.G., and Kullberg B.J. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems. J Microb Methods 49 (2002) 55-62
214. Dahlgren C., and Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 232 (1999) 3-14
215. Rodgers K. Measurement of the respiratory burst of leukocytes for immunotoxicologic analysis. In:. In: Burleson G.R., Dean J.H., and Munson A.E. (Eds). Methods in Immunotoxicology 2 (1995), Wiley-Liss, New York 67-77
216. Thiem P.A., Halper L.K., and Bloom J.C. Techniques for assessing canine mononuclear phagocyte function as part of an immunotoxicologic evaluation. Int J Immunopharmacol 10 (1988) 765-771
217. Schadelin J., Schadelin R., and Mandell G.L. Chemiluminescence of phagocytic cells. Crit Rev Clin Lab Sci 13 (1981) 1-19
218. Verdier F., Condevaux F., Tedone R., Virat M., and Descotes J. In vitro assessment of phagocytosis. Interspecies comparison of chemiluminescence response. Toxicol In Vitro 7 (1993) 317-320
219. Siegel J.P., and Remington J.S. Effects of antimicrobial agents on chemiluminescence of human polymorphonuclear leukocytes in response to phagocytosis. J Antimicrob Chemother 10 (1982) 505-515
220. Fromtling R.A., and Abruzzo G.K. Chemiluminescence as a tool for the evaluation of antimicrobial agent: a review. Methods Find Exp Clin Pharmacol 7 (1985) 493-500
221. Dumas R., Brouland J.P., Tedone R., and Descotes J. Influence of macrolide antibiotics on the chemiluminescence of zymosan-activated human neutrophils. Chemotherapy 36 (1990) 381-384
222. Lehmann A.K., Sornes S., and Halstensen A. Phagocytosis: measurement by flow cytometry. J Immunol Methods 243 (2000) 229-242
223. Lieberman M.E., Sachandiani D.M., and Pinney C.A. Comparative study of neutrophil activation by chemiluminescence and flow cytometry. Clin Diagn Lab Immunol 3 (1996) 654-662
224. Cretinon C., Condevaux F., Horand F., and Descotes J. Comparison of the phagocytic activity in rats and monkeys using two commercial kits. Toxicol Sci 72 Suppl. 1 (2003) 105 (abstract)
225. Gallin J.I., Wright D.G., Malech H., and Kirkpatrick C.H. Disorders of phagocyte chemotaxis. Ann Intern Med 92 (1980) 520-538
226. Eyraud A., Lombard J.Y., Descotes J., Laschi-Loquerie A., Tachon P., Veysseyre C., and Evreux J.C. Effects of erythromycin, josamycin and spiramycin on rat polymorphonuclear leukocyte chemotaxis. Chemotherapy 32 (1986) 379-782
227. Lombard J.Y., Descotes J., and Evreux J.C. Polymorphonuclear leucocyte chemotaxis little affected by three quinolones in vitro. J Antimicrob Chemother 20 (1988) 614-615
228. Miyagi T., Lam K.M., Chuang L.F., and Chuang R.Y. Suppression of chemokine-induced chemotaxis of monkey neutrophils and monocytes by chlorinated hydrocarbon insecticides. In Vivo 12 (1998) 441-446
229. Gauthier M., and Girard D. Activation of human neutrophils by chlordane: induction of superoxide production and phagocytosis but not chemotaxis or apoptosis. Hum Exp Toxicol 20 (2001) 229-235
230. Wilkinson P.C. Assays of leukocyte locomotion and chemotaxis. J Immunol Methods 216 (1998) 139-153
231. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115 (1962) 453-466
232. Nelson R.D., Quie P.G., and Simmons R.L. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115 (1975) 1650-1656
233. Yron I., Sahar A.D., Shohat L., and Efrati M. The analysis of measurements of murine natural killer cell activity. J Immunol Methods 79 (1985) 109-121
234. Bol S.J., Rosdorff H.J., Ronteltap C.P., and Hennen L.A. Cellular cytotoxicity assessed by the 51Cr release assay. Biological interpretation of mathematical parameters. J Immunol Methods 90 (1986) 15-23
235. Condevaux F., Guichard J., Forichon A., Aujoulat M., and Descotes J. Compared effects of morphine and nickel chloride on NK cell activity in vitro in rats and monkeys. J Appl Toxicol 21 (2001) 431-434
236. Chang L., Gusewitch G.A., Chritton D.B., Folz J.C., Lebeck L.K., and Nehlsen-Cannarella S.L. Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods 166 (1993) 45-54
237. Burchiel S.W., Kerkvliet N.L., Gerberick G.F., Lawrence D.A., and Ladics G.S. Assessment of immunotoxicity by multiparameter flow cytometry. Fundam Appl Toxicol 38 (1997) 38-54
238. Marcusson-Stahl M., and Cederbrant K. A flow-cytometric NK-cytotoxicity assay adapted for use in rat repeated dose toxicity studies. Toxicology 193 (2003) 269-279
239. Cederbrant K., Marcusson-Stahl M., Condevaux F., and Descotes J. NK-cell activity in immunotoxicity drug evaluation. Toxicology 185 (2003) 241-250
240. Condevaux F., Guichard J., Horand F., and Descotes J. Comparison of NK cell activity measurement using the 5 1 Cr release assay and FACS scan analysis: effect of a single iv dose of anti-asialo GM 1 in the rat. Toxicol Lett 144 (2003) 119 (abstract)
241. Introna M., Allavena P., Spreafico F., and Montovani A. Inhibition of human natural killer activity by cyclosporin A. Transplantation 31 (1981) 113-116
242. Gul X.-E., Rinaldo C.R., and Ho M. Natural killer cell activity in renal transplant recipients receiving cyclosporine. Infect Immun 41 (1983) 965-970
243. CPMP. Note for Guidance on Repeated Dose Toxicity Testing. CPMP/SWP/1042/99 (2000). http://www.health.gov.au/tga/docs/pdf/euguide/swp/104299en.pdf Document available at
244. FDA. Guidance for Industry: Immunotoxicology Evaluation of Investigational New Drugs (2002). http://www.fda.gov/cder/guidance/4945fnl.pdf Document available at
245. Ovtcharov R., Guentcheva G., and Michailova S. Some approaches to experimental testing of drugs for immunotoxicity. Arch Toxicol 4 (1980) 120-131
246. Sikorski E.E., McCay J.A., White K.L., Bradley S.G., and Munson A.E. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam Appl Toxicol 13 (1989) 843-858
247. White K.L., Lysy H.H., McCay J.A., and Anderson A.C. Modulation of serum complement levels following exposure to polychlorinated dibenzo p-dioxins. Toxicol Appl Pharmacol 84 (1986) 209-219
248. Burns L.A., Bradley S.G., and White K.L. Immunotoxicity of 2, 4-diaminotoluene in female B6C3F1 mice. Drug Chem Toxicol 17 (1994) 401-436
249. Dean J.H., Luster M.I., Boorman G.A., Luebke R.W., and Laser L.D. Application of tumor, bacterial, and parasite susceptibility assays to study immune alterations induced by environmental chemicals. Environ Health Perspect 43 (1982) 81-88
250. Thomas P.T., and Sherwood R.L. Host resistance models in immunotoxicology. In:. In: Smialowicz R.J., and Holsapple M.P. (Eds). Experimental Immunotoxicology (1996), CRC Press, Boca Raton 29-45
251. Wierda D. Can host resistance assays be used to evaluate the immunotoxicity of pharmaceuticals?. Hum Exp Toxicol 19 (2000) 244-245
252. Laschi-Loquerie A., Eyraud A., Morisset D., Sanou A., Tachon P., Veysseyre C., and Descotes J. Influence of heavy metals on the resistance of mice toward infection. Immunopharmacol Immunotoxicol 9 (1987) 235-241
253. Kern E.R. Use of viral infections in animal models to assess changes in the immune system. Environ Health Perspect 43 (1982) 71-79
254. Morahan P.S., Bradley S.G., and Munson A.E. Immunotoxic effects of diethylstilbestrol on host resistance: comparison with cyclophosphamide. J Leukoc Biol 35 (1984) 329-341
255. Selgrade M.J., Daniels M.J., Burleson G.R., Laser L.D., and Dean J.H. Effects of 7, 12dimethylbenz[a] anthracene, benzo[a]pyrene and cyclosporin A on murine cytomegalovirus infection: studies of resistance mechanisms. Int J Immunopharmacol 10 (1988) 811-818
256. Mogensen S.C. Host defences in mice against infections with herpes simplex virus. Microbiol Sci 1 (1984) 127-130
257. Selgrade M.K., Daniels M.J., and Dean J.H. Correlation between chemical suppression of natural killer cell activity in mice and susceptibility to cytomegalovirus: rationale for applying murine cytomegalovirus as a host resistance model and for interpreting immunotoxicity testing in terms of risk of disease. J Toxicol Environ Health 37 (1992) 123-137
258. Burleson G.R., Lebrec H., Yang Y.G., Ibanes J.D., Pennington K.N., and Birnbaum L.S. Effect of 2, 3, 7, 8-tetrachlorodibenzo p-dioxin (TODD) on influenza virus host resistance in mice. Fundam Appl Toxicol 29 (1996) 40-47
259. Lebrec H., and Burleson G.R. Influenza virus host resistance models in mice and rats: utilization for immune function assessment and immunotoxicology. Toxicology 91 (1994) 179-188
260. Bradley S.G. Listeria host resistance model. In:. In: Burleson G.R., Dean J.H., and Munson A.E. (Eds). Methods in Immunotoxicology 2 (1995), Wiley-Liss, New York 169-179
261. Meade B.J., Hayes B.B., and Klykken P.C. Development and validation of a Listeria monocytogenes host resistance model in female Fisher 344 rats. Toxicol Methods 8 (1998) 45-57
262. Bradley S.G. Streptococcus host resistance model. In:. In: Burleson G.R., Dean J.H., and Munson A.E. (Eds). Methods in Immunotoxicology 2 (1995), Wiley-Liss, New York 159-168
263. Luebke R.W. Assessment of host resistance to infection with rodent malaria. In:. In: Burleson G.R., Dean J.H., and Munson A.E. (Eds). Methods in Immunotoxicology 2 (1995), WileyLiss, New York 221-242
264. Descotes J., Brouland J.P., Tedone R., and Verdier F. Experimental toxoplasmosis in Swiss mice for assessing host resistance. Toxicologist 11 (1991) 207 (abstract)
265. Larsch J.E., and Kent D.E. The effect of alcohol on natural and acquired immunity of mice to infection with Trichinella spiralis. J Parasitol 35 (1949) 45-53
266. Cocker C.M. Effects of cortisone on Trichinella spiralis on non immunized mice. J Parasitol 41 (1955) 498-504
267. Doligalska M. Immune response to Trichinella spiralis larvae after treatment with the anti-allergic compound ketotifen. Parasitol Res 86 (2000) 232-238
268. Korenaga M., Watanabe N., Abe T., and Hashiguchi Y. Acceleration of IgE responses by treatment with recombinant interleukin-3 prior to infection with Trichinella spiralis in mice. Immunology 87 (1996) 642-646
269. De Waal E.J., De Jong W.H., Van der Stappen A.J., Verlaan B., and Van der Loveren H. Effects of salmeterol on host resistance to Trichinella spiralis in rats. Int J Immunopharmacol 21 (1999) 523-529
270. Vos J.G., De Klerk A., Kranjnc E., Van Loveren H., and Rozing J. Immunotoxicity of bis-tri-nbutyltin)-oxide in the rat: effects on thymus-dependent immunity and nonspecific resistance following long-term exposure in young versus aged rats. Toxicol Appl Pharmacol 105 (1990) 144-155
271. Fenwicj P.K., Aggett P.J., Macdonald D., Hubert C., and Wakelin D. Zinc deficiency and zinc repletion: effect on the response of rats to infection with Trichinella infection. Am J Clin Nutr 52 (1990) 166-172
272. Fugmann R.A., Aranyi C., Barbera P.W., Bradof J.N., Gibbons R.D., and Fenters J.D. The effect of diethylstilbestrol as measured by host resistance and tumor susceptibility assays in mice. J Toxicol Environ Health 11 (1983) 827-841
273. Luebke R.W., Luster M.I., Dean J.H., and Hayes H.T. Altered host resistance to Trichinella spiralis infection following subchronic exposure to diethylstilbestrol. Int J Immunopharmacol 6 (1984) 609-617
274. Luebke R.W., Copeland C.B., Diliberto J.J., Akubue P.I., Andrews D.L., Riddle M.M., Williams W.C., and Birnbaum L.S. Assessment of host resistance to Trichinella spiralis in mice following preinfection exposure to 2, 3, 7, 8-TODD. Toxicol Appl Pharmacol 125 (1994) 7-16
275. Luebke R.W., Copeland C.B., and Andrews D.L. Host resistance to Trichinella spiralis infection in rats exposed to 2, 3, 7, 8-tetrachlorodibenzo p-dioxin (TODD). Fundam Appl Toxicol 24 (1995) 285-289
276. Luebke R.W., Copeland C.B., and Andrews D.L. Effects of aging on resistance to Trichinella spiralis infection in rodents exposed to 2, 3, 7, 8-tetrachlorodibenzop-dioxin. Toxicology 136 (1999) 15-26
277. Steven W.M., Kumar S.N., Stewart G.L., and Seelig L.L. The effects of ethanol consumption on the expression of immunity to Trichinella spiralis in rats. Alcohol Clin Exp Res 14 (1990) 87-91
278. Seelig L.L., Steven W.M., and Stewart G.L. Effects of maternal ethanol consumption on the subsequent development of immunity to Trichinella spiralis in rat neonates. Alcohol Clin Exp Res 20 (1996) 514-522
279. Seelig L.L., Steven W.M., and Stewart G.L. Second generation effects of maternal ethanol consumption on immunity to Trichinella spiralis in female rats. Alcohol 34 (1999) 520-528
280. Bautista-Garfias C.R., Ixta O., Orduna M., Martinez F., Aguilar B., and Cortes A. Enhancement of resistance in mice treated with Lactobacillus casei: effect on Trichinella spiralis infection. Vet Parasitol 80 (1999) 251-260
281. Dessein A.J., Parker W.L., James S.L., and David J.R. IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophil response to Trichinella spiralis infection. J Exp Med 153 (1981) 423-436
282. Van Loveren H., Luebke R.W., and Vos J.G. Assessment of immunotoxicity with the parasitic infection model Trichinella spiralis. In:. In: Burleson G.R., Dean J.H., and Munson A.E. (Eds). Methods in Immunotoxicology 2 (1995), Wiley-Liss, New York 243-271
283. Ritterson A.L. Effect of immunosuppressive drugs (6-mercaptopurine and methotrexate) on resistance of Chinese hamsters to the tissue phase of Trichinella spiralis. J Infect Dis 118 (1968) 365-369
284. Behnke J.M., Dehlawi M.S., Rose R., Spyropoulos P.N., and Wakelin D. The response of hamsters to primary and secondary infection with Trichinella spiralis and to vaccination with parasite antigens. J Helminthol 68 (1994) 287-294
285. Dzik J.M., Zielinski Z., Golos B., Jagielska E., Wranicz M., and Walajtys-Rode E. Effect of cyclosporin A on immunological response in lungs of guinea pigs infected with Trichinella spiralis. Acta Biochim Pol 49 (2002) 233-247
286. Ivanoska D., Cuperlovic K., and Lunney J.K. Peripheral blood mononuclear cell subsets during Trichinella spiralis infection in pigs. Res Vet Sci 49 (1990) 92-97
287. Luebke R.W., Copeland C.B., Andrews D.L., Riddle M.M., and Smialowicz R.J. Host resistance to Trichinella spiralis in rats and mice: species-dependent effects of cyclophosphamide exposure. Toxicology 73 (1992) 305-321